Matthew A. Sleeman

6.5k total citations · 1 hit paper
82 papers, 3.8k citations indexed

About

Matthew A. Sleeman is a scholar working on Immunology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew A. Sleeman has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 18 papers in Physiology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew A. Sleeman's work include Asthma and respiratory diseases (17 papers), IL-33, ST2, and ILC Pathways (16 papers) and Immunotherapy and Immune Responses (13 papers). Matthew A. Sleeman is often cited by papers focused on Asthma and respiratory diseases (17 papers), IL-33, ST2, and ILC Pathways (16 papers) and Immunotherapy and Immune Responses (13 papers). Matthew A. Sleeman collaborates with scholars based in United States, United Kingdom and Canada. Matthew A. Sleeman's co-authors include Richard May, Krishnanand D. Kumble, J. Greg Murison, Deborah Clarke, Andrew Murphy, Jamie Orengo, Donna K. Finch, Lynne A. Murray, Vijay Mistry and Christopher E. Brightling and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew A. Sleeman

81 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

2019 330 citations Audrey Le Floc’h, Jeanne Allinne et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew A. Sleeman United States	33	1.5k	1.0k	921	853	553	82	3.8k
Shoichiro Ohta Japan	39	1.5k 1.0×	1.7k 1.6×	1.3k 1.4×	804 0.9×	629 1.1×	130	4.6k
Marcello Bagnasco Italy	35	1.3k 0.9×	1.2k 1.2×	386 0.4×	610 0.7×	1.4k 2.5×	164	4.2k
David P. Huston United States	33	1.7k 1.2×	1.4k 1.4×	431 0.5×	484 0.6×	751 1.4×	102	3.6k
Manel Juan Spain	36	1.7k 1.2×	423 0.4×	380 0.4×	827 1.0×	533 1.0×	180	4.1k
Jordi Yagüe Spain	41	2.4k 1.6×	668 0.7×	558 0.6×	2.3k 2.7×	433 0.8×	146	5.8k
Kazuhiko Arima Japan	37	2.7k 1.8×	1.8k 1.8×	618 0.7×	633 0.7×	1.1k 1.9×	84	5.3k
Ola Winqvist Sweden	40	2.1k 1.5×	408 0.4×	355 0.4×	932 1.1×	276 0.5×	128	4.6k
Mark B. Headley United States	20	1.9k 1.3×	637 0.6×	435 0.5×	698 0.8×	466 0.8×	32	3.7k
Oichi Kawanami Japan	33	659 0.5×	768 0.8×	2.0k 2.2×	1.1k 1.2×	221 0.4×	97	4.4k
Ryuta Nishikomori Japan	34	2.2k 1.5×	498 0.5×	321 0.3×	1.7k 2.0×	342 0.6×	148	4.0k

Countries citing papers authored by Matthew A. Sleeman

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Sleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Sleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Sleeman more than expected).

Fields of papers citing papers by Matthew A. Sleeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Sleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Sleeman. The network helps show where Matthew A. Sleeman may publish in the future.

Co-authorship network of co-authors of Matthew A. Sleeman

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Sleeman. A scholar is included among the top collaborators of Matthew A. Sleeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Sleeman. Matthew A. Sleeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srivatsan, Subhashini, Kirsten Nagashima, Wei Keat Lim, et al.. (2023). IL-4 And IL-13 Have Distinct And Overlapping Effects On Key Cell Types Involved In The Pathobiology Of Atopic Dermatitis. Journal of Allergy and Clinical Immunology. 151(2). AB149–AB149. 2 indexed citations

Asrat, Seblewongel, Kirsten Nagashima, G. Richard Scott, et al.. (2023). IL-33 Initiates and Amplifies Both Type 1 and Type 2 Inflammation. Journal of Allergy and Clinical Immunology. 151(2). AB126–AB126. 1 indexed citations

Asrat, Seblewongel, Joseph C. Devlin, Andrea Vecchione, et al.. (2023). TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells. Cell Reports Methods. 3(7). 100522–100522. 7 indexed citations

Wang, Claire Q., Sokol Haxhinasto, Sandra Garcet, et al.. (2022). Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis. Journal of Investigative Dermatology. 143(1). 87–97.e14. 12 indexed citations

Asrat, Seblewongel, Xia Liu, Li‐Hong Ben, et al.. (2020). Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory. Science Immunology. 5(43). 60 indexed citations

Benitez, Asiel A., Namita T. Gupta, Wen Zhang, et al.. (2020). Absence of central tolerance in Aire-deficient mice synergizes with immune-checkpoint inhibition to enhance antitumor responses. Communications Biology. 3(1). 355–355. 12 indexed citations

Dutton, Emma E., Claire Willis, Rémi Fiancette, et al.. (2019). Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations. Science Immunology. 4(35). 69 indexed citations

Vousden, Katherine A., T. Lundqvist, Bojana Popovic, et al.. (2019). Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1. Scientific Reports. 9(1). 1605–1605. 24 indexed citations

Leonard, Maureen M., Yu Bai, Gloria Serena, et al.. (2019). RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis. PLoS ONE. 14(4). e0215132–e0215132. 28 indexed citations

10.

Thijs, Judith L., Ian Strickland, Carla A.F.M. Bruijnzeel-Koomen, et al.. (2017). Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis. Journal of Allergy and Clinical Immunology. 140(3). 730–737. 119 indexed citations

11.

Désoubeaux, Guillaume, Janice M. Reichert, Matthew A. Sleeman, et al.. (2016). Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France. mAbs. 8(6). 999–1009. 39 indexed citations

12.

Ellson, Christian D., Rebecca Dunmore, Cory M. Hogaboam, Matthew A. Sleeman, & Lynne A. Murray. (2014). Danger-Associated Molecular Patterns and Danger Signals in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 51(2). 163–168. 52 indexed citations

13.

Vainshtein, Inna, Lorin Roskos, Jackie Cheng, et al.. (2014). Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals. Pharmaceutical Research. 32(1). 286–299. 26 indexed citations

14.

Sleeman, Matthew A., et al.. (2014). The epithelium in idiopathic pulmonary fibrosis: breaking the barrier. Frontiers in Pharmacology. 4. 173–173. 186 indexed citations

15.

Wang, Bing, Yvonne Lau, Meina Liang, et al.. (2011). Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 52(8). 1150–1161. 24 indexed citations

16.

Botelho, Fernando, Jake K. Nikota, Christoph Bauer, et al.. (2011). A mouse GM-CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette smoke. European Respiratory Journal. 38(2). 285–294. 19 indexed citations

17.

Campbell, Jamie I. D., et al.. (2010). Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis. British Journal of Pharmacology. 162(7). 1470–1484. 23 indexed citations

18.

Lowe, David C., S. Gerhardt, Alison Ward, et al.. (2010). Engineering a High-Affinity Anti-IL-15 Antibody: Crystal Structure Reveals an α-Helix in VH CDR3 as Key Component of Paratope. Journal of Molecular Biology. 406(1). 160–175. 14 indexed citations

19.

Wormstone, I. Michael, Lucy J. Dawes, Matthew A. Sleeman, Ian K. Anderson, & J.R. Reddan. (2008). FGF Promotes TGFbeta-Induced Matrix Contraction and Suppresses Expression of the Transdifferentiation Marker alphaSMA. Investigative Ophthalmology & Visual Science. 49(13). 3726–3726. 1 indexed citations

20.

Sleeman, Matthew A., J. Greg Murison, Ross L. Prestidge, et al.. (2000). B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR α-chemokine. International Immunology. 12(5). 677–689. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact